Similar Search Results

Have Newer Cardiovascular Drugs Reduced Hospitalization? Evidence From Longitudinal Country-Level Data on 20 OECD Countries, 1995-2003

Lichtenberg, Frank R. - 2008

Countries with larger increases in the share of cardiovascular drug doses that contained post-1990 or post-1995 ingredients had smaller increases in the cardiovascular disease hospital discharge rate, controlling for the quantity of cardiovascular medications consumed per person, the use of...

Persistent link: https://www.econbiz.de/10012464639

Has medical innovation reduced cancer mortality?

Lichtenberg, Frank R. - 2010

I analyze the effects of four types of medical innovation and cancer incidence on U.S. cancer mortality rates during …Under the assumption that there were no pre-dated factors that drove both innovation and mortality and that there would … have been parallel trends in mortality in the absence of innovation, the estimates indicate that there were three major …

Persistent link: https://www.econbiz.de/10012462770

Pharmaceutical innovation and the longevity of Australians : a first look

Lichtenberg, Frank R. - 2008

We examine the impact of pharmaceutical innovation on the longevity of Australians during the period 1995-2003. Due to …

Persistent link: https://www.econbiz.de/10012464638

Importation and Innovation

Lichtenberg, Frank R. - 2006

the elasticity of innovation with respect to the expected price of drugs should be at least as great as the elasticity of … innovation with respect to expected market size (disease incidence). I examine the cross-sectional relationship between … pharmaceutical innovation and market size among a set of diseases (different types of cancer) exhibiting substantial exogenous …

Persistent link: https://www.econbiz.de/10012466126

The Impact of New Laboratory Procedures and Other Medical Innovations on the Health of Americans, 1990-2003 : Evidence from Longitudinal, Disease-Level Data

Lichtenberg, Frank R. - 2006

higher rates of lab and outpatient innovation had greater declines in the probability of missing work during 1996-2003. This … for initial disability, the inverse relationship between lab innovation and disability changes disappears. This is because … there is a significant inverse relationship between initial health and the extent of laboratory innovation. But due to …

Persistent link: https://www.econbiz.de/10012466549

Institutions and Technological Innovation During the Early Economic Growth : Evidence from the Great Inventors of the United States, 1790-1930

Khan, B. Zorina - 2004

Employing a sample of renowned U.S. inventors that combines biographical detail with information on the patents they received over their careers, we highlight the impact of early U.S. patent institutions in providing broad access to economic opportunity and in encouraging trade in new...

Persistent link: https://www.econbiz.de/10012467721

Technological Innovations and Endogenous Changes in U.S. Legal Institutions, 1790-1920

Khan, B. Zorina - 2004

Recent scholarship highlights the importance of institutions to the processes of economic growth, but the precise nature of their relationship bears further examination. This paper considers how the evolution of legal institutions has contributed to, and in turn been affected by, major...

Persistent link: https://www.econbiz.de/10012468347

The impact of new drug launches on longevity : evidence from longitudinal disease-level data from 52 countries, 1982-2001

Lichtenberg, Frank R. - 2003

We perform an econometric analysis of the effect of new drug launches on longevity, using data from the IMS Health Drug Launches database and the WHO Mortality Database. Our data cover virtually all of the diseases borne by people in 52 countries during the period 1982-2001, and enable us to...

Persistent link: https://www.econbiz.de/10012468944

Pharmaceutical Innovation, Mortality Reduction, and Economic Growth

Lichtenberg, Frank R. - 1998

We perform an econometric investigation of the contribution of pharmaceutical innovation to mortality reduction and … pharmaceutical innovation, there would have been no increase and perhaps even a small decrease in mean age at death, and that new … drugs have increased life expectancy, and lifetime income, by about 0.75-1.0% per annum. The drug innovation measures are …

Persistent link: https://www.econbiz.de/10012472240

The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality

Lichtenberg, Frank R. - 1996

This paper presents an econometric analysis of the effect of changes in the quantity and type of pharmaceuticals prescribed by physicians in outpatient visits on rates of hospitalization, surgical procedure, mortality, and related variables. It examines the statistical relationship across...

Persistent link: https://www.econbiz.de/10012473446